Condition: ENT Disorder · Nasal Procedures · Nasal Anesthesia · Sponsor: Noden Pharma
The purpose of this study is to assess the pharmacokinetic (PK) properties, safety and tolerability following a single dose administration of GOPRELTO® or NUMBRINO™ as an anesthetic for diagnostic procedures and surgeries on or through the mucous membranes of the nasal cavities in pediatric adolescent subjects.
This description comes directly from the study's public registry record.
Robert Puchlaski, M.D · 803-256-7076; 803-549-2467 · rpuchalski@me.com
Always discuss trial participation with your own doctor first.
| SCENT Sleep and Allergy, 110 Highland Center Drive | Columbia, South Carolina, United States | Recruiting |
| SCENT Sleep and Allergy, 145 Park Central | Columbia, South Carolina, United States | Recruiting |
| South Carolina ENT, Sleep and Allergy | Columbia, South Carolina, United States | Recruiting |
| SCENT Sleep and Allergy, 15 Exchange Dr. | Lugoff, South Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04792034